| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high-affinity IgG receptor activity | 1.96e-05 | 2 | 89 | 2 | GO:0019771 | |
| GeneOntologyMolecularFunction | leukotriene receptor binding | 1.96e-05 | 2 | 89 | 2 | GO:0031774 | |
| GeneOntologyMolecularFunction | IgG receptor activity | 4.07e-04 | 7 | 89 | 2 | GO:0019770 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | RFTN1 RNF168 FCGR1A FCGR1BP AGER SOCS5 PAXIP1 CD70 CD74 IRF4 | 3.33e-05 | 462 | 90 | 10 | GO:0002460 |
| GeneOntologyBiologicalProcess | male mating behavior | 3.52e-05 | 15 | 90 | 3 | GO:0060179 | |
| GeneOntologyBiologicalProcess | positive regulation of phagocytosis, engulfment | 6.25e-05 | 18 | 90 | 3 | GO:0060100 | |
| GeneOntologyBiologicalProcess | positive regulation of membrane invagination | 6.25e-05 | 18 | 90 | 3 | GO:1905155 | |
| GeneOntologyBiologicalProcess | positive regulation of transcription by RNA polymerase II | TET2 KMT2C ZNF142 USF3 ALX1 HDAC4 KLF10 BRCA1 CSRNP3 CIITA NFKBIA PAXIP1 NCOA1 IRF4 KAT6B AGRN CRTC2 | 9.37e-05 | 1390 | 90 | 17 | GO:0045944 |
| GeneOntologyBiologicalProcess | positive regulation of neuron apoptotic process | 1.21e-04 | 110 | 90 | 5 | GO:0043525 | |
| GeneOntologyBiologicalProcess | regulation of phagocytosis, engulfment | 1.52e-04 | 24 | 90 | 3 | GO:0060099 | |
| GeneOntologyBiologicalProcess | regulation of membrane invagination | 1.72e-04 | 25 | 90 | 3 | GO:1905153 | |
| GeneOntologyBiologicalProcess | type III hypersensitivity | 1.87e-04 | 5 | 90 | 2 | GO:0001802 | |
| GeneOntologyBiologicalProcess | regulation of type III hypersensitivity | 1.87e-04 | 5 | 90 | 2 | GO:0001803 | |
| GeneOntologyBiologicalProcess | positive regulation of type III hypersensitivity | 1.87e-04 | 5 | 90 | 2 | GO:0001805 | |
| GeneOntologyBiologicalProcess | regulation of immune response | RFTN1 FCGR1A FCGR1BP AGER INPPL1 SOCS5 NFKBIA PAXIP1 CD74 IRF4 LAMP2 GRN ZNRF4 BTN2A1 | 2.45e-04 | 1085 | 90 | 14 | GO:0050776 |
| MousePheno | abnormal macrophage antigen presentation | 1.18e-05 | 10 | 66 | 3 | MP:0002454 | |
| Pubmed | Macrophages Maintain Epithelium Integrity by Limiting Fungal Product Absorption. | 1.90e-07 | 5 | 94 | 3 | 32970988 | |
| Pubmed | SOX5 TET2 EPC2 KMT2C KLF10 AGO3 BRCA1 NFKBIA PAXIP1 XRN1 SUGP1 NCOA1 IRF4 GRN FIGN | 6.56e-06 | 1429 | 94 | 15 | 35140242 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 28814603 | ||
| Pubmed | Features and protective efficacy of human mAbs targeting Mycobacterium tuberculosis arabinomannan. | 7.23e-06 | 2 | 94 | 2 | 37733444 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 9257847 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 25231998 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 30190171 | ||
| Pubmed | Molecular cloning and expression of the mouse high affinity Fc receptor for IgG. | 7.23e-06 | 2 | 94 | 2 | 2136886 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 26880370 | ||
| Pubmed | FcRγ deficiency improves survival in experimental sepsis by down-regulating TLR4 signaling pathway. | 7.23e-06 | 2 | 94 | 2 | 30552619 | |
| Pubmed | Sensory Neuron Expressed FcγRI Mediates Postinflammatory Arthritis Pain in Female Mice. | 7.23e-06 | 2 | 94 | 2 | 35833115 | |
| Pubmed | Differential gene expression modulated by the cytoplasmic domain of Fc gamma RIa (CD64) alpha-chain. | 7.23e-06 | 2 | 94 | 2 | 15528358 | |
| Pubmed | Fc receptors and the common gamma-chain in experimental autoimmune encephalomyelitis. | 7.23e-06 | 2 | 94 | 2 | 14991835 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 1402657 | ||
| Pubmed | Mouse FcgammaRI: identification and functional characterization of five new alleles. | 7.23e-06 | 2 | 94 | 2 | 10752630 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 31211699 | ||
| Pubmed | Steroid receptor coactivator 1 links the steroid and interferon gamma response pathways. | 7.23e-06 | 2 | 94 | 2 | 12933903 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 16849450 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 38524127 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 8294875 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 8077658 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 28289219 | ||
| Pubmed | Amelioration of Lupus Serum-Induced Skin Inflammation in CD64-Deficient Mice. | 7.23e-06 | 2 | 94 | 2 | 35273604 | |
| Pubmed | IgG3-mediated enhancement of the antibody response is normal in Fc gammaRI-deficient mice. | 7.23e-06 | 2 | 94 | 2 | 16305642 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 21124939 | ||
| Pubmed | Macrophages eliminate circulating tumor cells after monoclonal antibody therapy. | 7.23e-06 | 2 | 94 | 2 | 24430180 | |
| Pubmed | Expression of modified FcγRI enables myeloid cells to elicit robust tumor-specific cytotoxicity. | 7.23e-06 | 2 | 94 | 2 | 38885133 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 23624750 | ||
| Pubmed | Novel Fc gamma receptor I family gene products in human mononuclear cells. | 7.23e-06 | 2 | 94 | 2 | 1430234 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 15835266 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 8663283 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 1830050 | ||
| Pubmed | Functional characteristics of the high affinity IgG receptor, FcγRI. | 7.23e-06 | 2 | 94 | 2 | 21325219 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 8611682 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 16409296 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 30744065 | ||
| Pubmed | Serum anti-Fcgamma receptor autoantibodies in patients with alopecia areata. | 7.23e-06 | 2 | 94 | 2 | 17124586 | |
| Pubmed | Linkage on chromosome 3 of autoimmune diabetes and defective Fc receptor for IgG in NOD mice. | 7.23e-06 | 2 | 94 | 2 | 8480181 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 8566965 | ||
| Pubmed | Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies. | 7.23e-06 | 2 | 94 | 2 | 29576375 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 18245810 | ||
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 8478020 | ||
| Pubmed | FcγR-binding affinity of monoclonal murine IgG1s carrying different N-linked Fc oligosaccharides. | 7.23e-06 | 2 | 94 | 2 | 31554601 | |
| Pubmed | 7.23e-06 | 2 | 94 | 2 | 23055523 | ||
| Pubmed | The involvement of FcR mechanisms in antibody-mediated rejection. | 7.23e-06 | 2 | 94 | 2 | 18049118 | |
| Pubmed | 7.87e-06 | 493 | 94 | 9 | 15368895 | ||
| Pubmed | Neonatal Fc receptor for IgG regulates mucosal immune responses to luminal bacteria. | 2.16e-05 | 3 | 94 | 2 | 16841095 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 22003208 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 12594281 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 15880819 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 28924242 | ||
| Pubmed | IRF-4-mediated CIITA transcription is blocked by KSHV encoded LANA to inhibit MHC II presentation. | 2.16e-05 | 3 | 94 | 2 | 24204280 | |
| Pubmed | FcγRI mediates serum amyloid P inhibition of fibrocyte differentiation. | 2.16e-05 | 3 | 94 | 2 | 22493081 | |
| Pubmed | Neurofibromatosis with male breast cancer--risk factor or co-incidence? Report of two rare cases. | 2.16e-05 | 3 | 94 | 2 | 25267367 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 24161960 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 19657115 | ||
| Pubmed | Fc-optimized antibodies elicit CD8 immunity to viral respiratory infection. | 2.16e-05 | 3 | 94 | 2 | 33032297 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 9763663 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 30297432 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 12875993 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 24829461 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 12427132 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 18279703 | ||
| Pubmed | MicroRNA-127 inhibits lung inflammation by targeting IgG Fcγ receptor I. | 2.16e-05 | 3 | 94 | 2 | 22287715 | |
| Pubmed | Tpl2 kinase regulates FcγR signaling and immune thrombocytopenia in mice. | 2.16e-05 | 3 | 94 | 2 | 23898046 | |
| Pubmed | Bridging channel dendritic cells induce immunity to transfused red blood cells. | 2.16e-05 | 3 | 94 | 2 | 27185856 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 32855215 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 9892619 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 30636035 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 26056254 | ||
| Pubmed | The essential role of complement in antibody-mediated resistance to Salmonella. | 2.16e-05 | 3 | 94 | 2 | 30179254 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 8697799 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 23728777 | ||
| Pubmed | The lysosomal protein cathepsin L is a progranulin protease. | 2.16e-05 | 3 | 94 | 2 | 28743268 | |
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 16543474 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 23776173 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 37207276 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 12707052 | ||
| Pubmed | 2.16e-05 | 3 | 94 | 2 | 26500140 | ||
| Pubmed | C1q-Dependent Dendritic Cell Cross-Presentation of In Vivo-Formed Antigen-Antibody Complexes. | 2.16e-05 | 3 | 94 | 2 | 28432146 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 9551950 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 15242870 | ||
| Pubmed | miR-138 activates NF-κB signaling and PGRN to promote rheumatoid arthritis via regulating HDAC4. | 4.32e-05 | 4 | 94 | 2 | 31492495 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 16517729 | ||
| Pubmed | Unveiling skin macrophage dynamics explains both tattoo persistence and strenuous removal. | 4.32e-05 | 4 | 94 | 2 | 29511065 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 31562320 | ||
| Pubmed | Fc receptor regulation of protective immunity against Chlamydia trachomatis. | 4.32e-05 | 4 | 94 | 2 | 11872097 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 9490697 | ||
| Pubmed | Glycoprotein VI-dependent and -independent pathways of thrombus formation in vivo. | 4.32e-05 | 4 | 94 | 2 | 16455953 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 16452176 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 28028748 | ||
| Pubmed | Fc receptor-mediated antibody regulation of T cell immunity against intracellular pathogens. | 4.32e-05 | 4 | 94 | 2 | 12898452 | |
| Pubmed | Fcgamma receptor cross-linking stimulates cell proliferation of macrophages via the ERK pathway. | 4.32e-05 | 4 | 94 | 2 | 19996316 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 27869616 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 15753034 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 12705859 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 21552324 | ||
| Pubmed | Immune complex-loaded dendritic cells are superior to soluble immune complexes as antitumor vaccine. | 4.32e-05 | 4 | 94 | 2 | 16585547 | |
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 17182593 | ||
| Pubmed | 4.32e-05 | 4 | 94 | 2 | 19890047 | ||
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-06 | 169 | 94 | 6 | 30141f76e9bfc2b4586429857c72dbc85ba65cc9 | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.53e-06 | 194 | 94 | 6 | bde6830a281f7cd7fd1733e40a41ddd2673ba88e | |
| ToppCell | COVID_non-vent|World / Disease condition, Lineage, Cell class and subclass | 4.21e-06 | 200 | 94 | 6 | accef1050963dc91e189ac3d38228f15bf57e06e | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_interstitial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.41e-05 | 145 | 94 | 5 | 778655fffd73df101e656154a41b478a1b695116 | |
| ToppCell | droplet-Liver-LIVER_HEPATOCYTES-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.79e-05 | 167 | 94 | 5 | cf6206c506715cd846799c62cf7c06e3fa99f7af | |
| ToppCell | 367C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.21e-05 | 172 | 94 | 5 | da959c1abadafd79b7a0088a25eb8ef8efa3a0c2 | |
| ToppCell | NS-critical-d_07-13-Lymphoid-B_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.68e-05 | 177 | 94 | 5 | d4db058c09012ec9fbde61277a9f86d9956de8fc | |
| ToppCell | NS-moderate-d_16-33-Lymphoid-B_cell|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 3.68e-05 | 177 | 94 | 5 | 320fd77c7c98e9305dcc34a168ec9d674539ed65 | |
| ToppCell | Mild-CD4+_T|Mild / Disease group and Cell class | 4.54e-05 | 185 | 94 | 5 | c28ecb63146de1b02418e5a4fad0ae7c2b66a41d | |
| ToppCell | moderate-Lymphoid-B_cell|moderate / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 4.66e-05 | 186 | 94 | 5 | fd2c4c3e8929ca5d64f6c5064e5f3d3d6ba07b5f | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Adaptive_/_Maladaptive_/_Repairing_Proximal_Tubule_Epithelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.16e-05 | 190 | 94 | 5 | 989d4eefd22d66ecb857836f8fdbcf41e3047f84 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_B-B_cell-B_c03-CD27-AIM2|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.16e-05 | 190 | 94 | 5 | 0db545a4cba7534bad2693e0d565cde7dbc7a586 | |
| ToppCell | Control-Myeloid-cDC2|Control / Disease state, Lineage and Cell class | 5.16e-05 | 190 | 94 | 5 | 4e481e42353d47af7991744000403af2873f6a41 | |
| ToppCell | IPF-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 5.29e-05 | 191 | 94 | 5 | 9fda87fb6bc5b8b6c0214ec909ebbc9f3f65319b | |
| ToppCell | COPD-Myeloid-cDC2|World / Disease state, Lineage and Cell class | 5.29e-05 | 191 | 94 | 5 | 4e4887175200a57e1b041f2f131e3df774df3509 | |
| ToppCell | tumor_Lung-Myeloid_cells-Alveolar_Mac|tumor_Lung / Location, Cell class and cell subclass | 5.42e-05 | 192 | 94 | 5 | 44eda67501e69799c5981be602c143d12f5f222f | |
| ToppCell | IPF-Myeloid-cDC2|IPF / Disease state, Lineage and Cell class | 5.42e-05 | 192 | 94 | 5 | fe1de692fec48cba4a9bbc6eaa257260e8b4e800 | |
| ToppCell | moderate-Lymphoid-B_cell|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 5.42e-05 | 192 | 94 | 5 | ae3727503c3b9f4695e565fd3161cc33b898f349 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Monocytes|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 5.56e-05 | 193 | 94 | 5 | ddbd8944661ac3b0b5fe63471bdc24ba05598017 | |
| ToppCell | PCW_10-12-Hematologic_Myeloid-Hem_Myeloid_monocytic-im_myeloid_progenitor3_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 5.83e-05 | 195 | 94 | 5 | c707885d092aedbbe14f51f7de4a5911c9214289 | |
| ToppCell | 356C-Myeloid-Dendritic-cDC2|356C / Donor, Lineage, Cell class and subclass (all cells) | 5.83e-05 | 195 | 94 | 5 | 4c9a2167d8cfe40dfd609c303ada5b5ef800bd8f | |
| ToppCell | healthy_donor-Myeloid-Dendritic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.98e-05 | 196 | 94 | 5 | ea590b8ea3d13ff93cb5863a44936b0cfdf3b868 | |
| ToppCell | 3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.98e-05 | 196 | 94 | 5 | 173d2c38a01c9ae1c50657d5fc383238aed4aacb | |
| ToppCell | healthy_donor-Myeloid-Dendritic-cDC|healthy_donor / Disease condition, Lineage, Cell class and subclass | 5.98e-05 | 196 | 94 | 5 | aac79fc45cab4a16e2fa02652ece0999591261a5 | |
| ToppCell | IIH-granulo1-|IIH / Condition, Cell_class and T cell subcluster | 6.12e-05 | 197 | 94 | 5 | 51be6d5652b17c70f3a33f244efc3b728ec56f5b | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.12e-05 | 197 | 94 | 5 | 4f022bae7af2ca23689cc0d35046a7e23dba6e9c | |
| ToppCell | systemic_lupus_erythematosus-managed-Myeloid-classical_monocyte-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex | 6.12e-05 | 197 | 94 | 5 | 5a81796c813bab9f8b7aedfd5e3a6a58c257837b | |
| ToppCell | IIH-granulo1|IIH / Condition, Cell_class and T cell subcluster | 6.12e-05 | 197 | 94 | 5 | 39637e8b726bc58c0a6885c49713111f97aff881 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.12e-05 | 197 | 94 | 5 | 69671ed173057a67265ac39ed03fbd57dbd22c5c | |
| ToppCell | nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.12e-05 | 197 | 94 | 5 | a902aa05e5f711bcfdd9e19749ab636b597eb116 | |
| ToppCell | COVID-19_Moderate-Classical_Monocyte|World / disease group, cell group and cell class | 6.12e-05 | 197 | 94 | 5 | 16cf3939e700aef1e16159f0652ba2dfad287e7a | |
| ToppCell | 390C-Myeloid-Dendritic|390C / Donor, Lineage, Cell class and subclass (all cells) | 6.12e-05 | 197 | 94 | 5 | 424526c94b9a73c1c28ddc65dfba53aba5c6b2d2 | |
| ToppCell | Sigmoid-B_cell-B_cell_IgG_Plasma|B_cell / Region, Cell class and subclass | 6.27e-05 | 198 | 94 | 5 | 305d7ae9b070ac7211638a5282374c02bf13af40 | |
| ToppCell | Parenchyma_COVID-19-Immune-TX-MoAM-4|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 6.27e-05 | 198 | 94 | 5 | a7eed9eeb728a8796e2780090cc244856efd8c65 | |
| ToppCell | BLOOD--(3)_Intermediate_monocytes| / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2) | 6.27e-05 | 198 | 94 | 5 | 61685a86f70a7d2a6d3260b76081119978c15661 | |
| ToppCell | Tracheal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-05 | 199 | 94 | 5 | 744b63fba33b176ab7dde11646ccb313665505f7 | |
| ToppCell | severe-B_memory|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.42e-05 | 199 | 94 | 5 | 6d3436dd65d525aaa23ec02672005380f21c4d0f | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.42e-05 | 199 | 94 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 6.42e-05 | 199 | 94 | 5 | 60e6312a149e23e4b486d92fb1f9625960b69c9d | |
| ToppCell | Severe-B_intermediate-6|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 6.42e-05 | 199 | 94 | 5 | bf6ebb63ab361d9d1946225894d7be433e9befab | |
| ToppCell | 390C-Myeloid-Dendritic|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 6.58e-05 | 200 | 94 | 5 | 3935b6ff3ae32d170a268538c756ee34ed2308d4 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic-CD14+_Monocyte|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.58e-05 | 200 | 94 | 5 | 465ed50e0b92bb8c27ffe56d816f063a45b52be9 | |
| ToppCell | COVID_non-vent-Myeloid|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.58e-05 | 200 | 94 | 5 | a40768e8e58c86b8e20bc188b9274ebe412fc765 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 6.58e-05 | 200 | 94 | 5 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | COVID_non-vent-Myeloid-Monocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 6.58e-05 | 200 | 94 | 5 | 4243a9d32f3a11141284d0d944cb81194b532876 | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 1.43e-04 | 125 | 94 | 4 | 43aa4b77dccf0ea2979218826af16034f2017c3a | |
| ToppCell | TCGA-Blood_and_Bone_Marrow-Primary_Blood_Derived_Cancer_-_Peripheral_Blood-Leukemia-Acute_Myeloid_Leukemia-4|TCGA-Blood_and_Bone_Marrow / Sample_Type by Project: Shred V9 | 1.47e-04 | 126 | 94 | 4 | ef456fb97c28bc234431f70bd935994225bfbf21 | |
| ToppCell | LPS_only-Myeloid-Dendritic_cells-mDC|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.65e-04 | 147 | 94 | 4 | 26bd9d89e2e7b841cc18030bb7cebb642b987183 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.87e-04 | 150 | 94 | 4 | 53de595376a9fc92491dfd58ff25938b0bf79903 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Lymphocytic-Lymphocytic_B-B_cell|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.87e-04 | 150 | 94 | 4 | e4b40b3243ed26d0c46bf196ac06e148834e7ed2 | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC-cDC2|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-04 | 152 | 94 | 4 | cefc0ab592e99badf145fb95adf9906cb81be81c | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-04 | 152 | 94 | 4 | c8faa83dcaddb2ce2bb890f90dd8e676f7dcb1b3 | |
| ToppCell | PND01-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.02e-04 | 152 | 94 | 4 | c3f00beb8b6fde99263d5ed6bbe3c2415d02f91d | |
| ToppCell | Fetal_29-31_weeks-Immune-dendritic_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.25e-04 | 155 | 94 | 4 | 9f937ae48767fdcf1a944af4de0530d9c0ab441d | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Dendritic-conventional_dendritic_cell-DC_c1-CLEC9A|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.25e-04 | 155 | 94 | 4 | d76a0f99ec35560d18820f9c92b69364ef2250e3 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 156 | 94 | 4 | 5caefdc6cc86f2ac52abe8c8da821db14f476915 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-megakaryocyte-erythroid_progenitor_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.33e-04 | 156 | 94 | 4 | 758f57dc10fc5cad200bf5b310c10ec9b1405f23 | |
| ToppCell | COVID-19-Myeloid-Dendritic_cells|COVID-19 / group, cell type (main and fine annotations) | 3.33e-04 | 156 | 94 | 4 | a07a9096799e4ba663841c70035b4b32c1fda4f9 | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_B-B_cell-B_c01-TCL1A|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.58e-04 | 159 | 94 | 4 | 1dde4d19cc0fde7ebbccb4c31bb845a92206021b | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-04 | 160 | 94 | 4 | e9e52532131cdc3fb01e81cfc046e3f670cc8e75 | |
| ToppCell | PND01-03-samps|World / Age Group, Lineage, Cell class and subclass | 3.75e-04 | 161 | 94 | 4 | 1973b112d8d67aacc02751797d0148e7b53bfa66 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Myeloid-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.84e-04 | 162 | 94 | 4 | b502d6af6868425b5c919740e011330c0d3cf3b8 | |
| ToppCell | saliva-Severe-critical_progression_d28-40-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.93e-04 | 163 | 94 | 4 | d005115aa1e1458b51de7eb719794617a4168608 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.02e-04 | 164 | 94 | 4 | 17d5b8bb7c015cf9f0d6e578a0d212eada39cb93 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-plasma_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-04 | 164 | 94 | 4 | 758e85e2f5e7236b345e16c78344d5e0bf17d8dc | |
| ToppCell | 356C-Myeloid-Macrophage-SPP1+_Macrophage|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.02e-04 | 164 | 94 | 4 | d6806deabf5f5c355934387be2baae125ac33fb8 | |
| ToppCell | Adult-Immune-dendritic_cell|Adult / Lineage, Cell type, age group and donor | 4.11e-04 | 165 | 94 | 4 | 073f52698dac1fe4edd7410865f81b30e1c7196a | |
| ToppCell | droplet-Fat-SCAT-30m-Lymphocytic-B_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.21e-04 | 166 | 94 | 4 | 4b31d2755108b2815316411a38bfb11fd30ef98a | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-04 | 166 | 94 | 4 | 60060b03f2abfa3cc08107ab5a9f578e60e4ae16 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-04 | 166 | 94 | 4 | ec9161d388db5a257b8d125c14f9dd911d5d5d4a | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage-macrophage,_alveolar|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.21e-04 | 166 | 94 | 4 | 28a44448a0b0d72459e8fe84ce5d666f16f514b3 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Epithelial_transtional-secretory-tracheobronchial_goblet_cell-Goblet_(subsegmental)-|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.21e-04 | 166 | 94 | 4 | 4586d6725403f879fc96f67be579022587ce1906 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Macrophage|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.21e-04 | 166 | 94 | 4 | 2a04915d534a83e65aa168435d6856125b5bdd78 | |
| ToppCell | Thalamus-Macroglia-POLYDENDROCYTE|Thalamus / BrainAtlas - Mouse McCarroll V32 | 4.31e-04 | 167 | 94 | 4 | 1e144c03409df94ccd39760842590e8ea7487e29 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.31e-04 | 167 | 94 | 4 | 942134bbabe9972fae80cbc4ed4e94da52f55dc3 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 4.31e-04 | 167 | 94 | 4 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | normal_Lung-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass | 4.40e-04 | 168 | 94 | 4 | 76b49463895cdef27c90f831c6246bcb92b9761b | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.40e-04 | 168 | 94 | 4 | ca94b29c1030484143a77f2df06dad74d2c6136e | |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_B-ABC_aged-B_naive|lymph-node_spleen / Manually curated celltypes from each tissue | 4.40e-04 | 168 | 94 | 4 | 494d5a11154ff22fedb25f4036d730cef376da60 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-CD45____B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 169 | 94 | 4 | d44fc49056799dfc70a3c7d538c210d88ffded05 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Monocytic-Classical_Monocyte-Mono_c2-CD14-HLA-DPB1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.50e-04 | 169 | 94 | 4 | d4bd489ebdb86e70ed5e3dbbe8518c6cae2197e5 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.50e-04 | 169 | 94 | 4 | 14aadc2d1bf66eb47dac33b4d61ddb3c942caa4f | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.50e-04 | 169 | 94 | 4 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | wk_08-11-Hematologic_Lymphocytic-B-Late_pro-B|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 4.60e-04 | 170 | 94 | 4 | ad69ebfda452e19eedc453e1d07dacb844d64e47 | |
| ToppCell | droplet-Lung-nan-21m-Myeloid-myeloid_dendritic_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 170 | 94 | 4 | 71c52fadecc6b4bfe98692b266adaa1406f6d56d | |
| ToppCell | droplet-Liver-LIVER_NPC-30m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 170 | 94 | 4 | a121e10099faaeb60251eec162f38caf7c4238c2 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid-professional_antigen_presenting_cell|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 170 | 94 | 4 | 29deb285d5a82c0abcc108012ca42f4b4b4d9e19 | |
| ToppCell | droplet-Thymus-nan-21m-Myeloid|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 170 | 94 | 4 | dc35d66a9a9fe6cdd7f4ec0fe7efa49d02f2b5b2 | |
| ToppCell | droplet-Kidney-nan-21m-Lymphocytic-B_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.60e-04 | 170 | 94 | 4 | 53fd50c9a27d47662fbcbd7e9e9837f72ac448c5 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c5-CD16|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.71e-04 | 171 | 94 | 4 | 87d652afbb375f8ee50e5faecf6085630cd2163c | |
| ToppCell | facs-Trachea-3m-Mesenchymal-fibroblast-fibroblast_of_trachea-tracheal_fibroblast_l15|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 4.81e-04 | 172 | 94 | 4 | de4961f4037c439d3e0ec706a257b0ec17f4d5be | |
| ToppCell | droplet-Liver|droplet / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.81e-04 | 172 | 94 | 4 | cd0e8f48836a16026b47ade06abadf26b53f581f | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.81e-04 | 172 | 94 | 4 | c32e6af9e2d29da47b5d870207b598cff11aef6c | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic-Neutrophil-Neu_c1-IL1B|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.81e-04 | 172 | 94 | 4 | 0b247fe57163af08132db8df42e6757699885295 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Myeloid-Granulocytic|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.81e-04 | 172 | 94 | 4 | 1a0556c97fcba126126c22adea5235d977d41ebe | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_activated|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.92e-04 | 173 | 94 | 4 | 94f99f7e7813d6e53e0bedf97087400b1bf00129 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass | 4.92e-04 | 173 | 94 | 4 | 4efa0878ed1ede8fa5d6c191a76d4f70558ba761 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar-Macro_c6-VCAN|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.03e-04 | 174 | 94 | 4 | eaaf17a06efc09ed4752b449827b1f0f424d3dad | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.13e-04 | 175 | 94 | 4 | 393da565f61ba640410419a0cabaaf5c1056580a | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Dendritic-dendritic_cell-Migratory_DCs|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 5.13e-04 | 175 | 94 | 4 | 271b56d4ab940959d28ca4b86ce2750350dfc717 | |
| Disease | Congenital myasthenic syndrome ib | 2.94e-05 | 3 | 93 | 2 | C1850792 | |
| Disease | Intellectual Disability | 8.62e-05 | 447 | 93 | 8 | C3714756 | |
| Disease | gas trapping measurement | 1.04e-04 | 29 | 93 | 3 | EFO_0007628 | |
| Disease | peak expiratory flow | 1.81e-04 | 498 | 93 | 8 | EFO_0009718 | |
| Disease | middle cerebral artery infarction (biomarker_via_orthology) | 2.18e-04 | 93 | 93 | 4 | DOID:3525 (biomarker_via_orthology) | |
| Disease | Leukemia, Myelocytic, Acute | 2.24e-04 | 173 | 93 | 5 | C0023467 | |
| Disease | esophagus squamous cell carcinoma (is_implicated_in) | 3.91e-04 | 45 | 93 | 3 | DOID:3748 (is_implicated_in) | |
| Disease | femoral neck bone mineral density | 3.98e-04 | 196 | 93 | 5 | EFO_0007785 | |
| Disease | Peripheral T-Cell Lymphoma | 4.35e-04 | 10 | 93 | 2 | C0079774 | |
| Disease | Malignant neoplasm of breast | NF1 HDAC4 BRCA1 ARFGAP3 NFKBIA NCOA1 NHS CD74 DLEC1 CUBN KAT6B | 5.64e-04 | 1074 | 93 | 11 | C0006142 |
| Disease | Global developmental delay | 8.45e-04 | 133 | 93 | 4 | C0557874 | |
| Disease | diffuse large B-cell lymphoma | 8.72e-04 | 14 | 93 | 2 | EFO_0000403 | |
| Disease | nasopharynx carcinoma (is_implicated_in) | 1.00e-03 | 15 | 93 | 2 | DOID:9261 (is_implicated_in) | |
| Disease | nevus count | 1.45e-03 | 18 | 93 | 2 | EFO_0004632 | |
| Disease | prostate cancer (is_marker_for) | 1.52e-03 | 156 | 93 | 4 | DOID:10283 (is_marker_for) | |
| Disease | stomach cancer (is_implicated_in) | 1.54e-03 | 72 | 93 | 3 | DOID:10534 (is_implicated_in) | |
| Disease | glaucoma (is_marker_for) | 1.80e-03 | 20 | 93 | 2 | DOID:1686 (is_marker_for) | |
| Disease | lung non-small cell carcinoma (is_marker_for) | 2.04e-03 | 169 | 93 | 4 | DOID:3908 (is_marker_for) | |
| Disease | acute myeloid leukemia (is_implicated_in) | 2.40e-03 | 84 | 93 | 3 | DOID:9119 (is_implicated_in) | |
| Disease | stomach carcinoma (is_marker_for) | 2.59e-03 | 24 | 93 | 2 | DOID:5517 (is_marker_for) | |
| Disease | Noonan Syndrome | 2.59e-03 | 24 | 93 | 2 | C0028326 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| HHVRLERTSPCQDSS | 61 | Q15699 | |
| SCHSLSERGLHSPSQ | 1621 | Q68DN1 | |
| HSPSERSHCSPSERS | 1751 | Q68DN1 | |
| GHTTTNHLIPALCTS | 701 | Q52LR7 | |
| SLIHLVGPSDCTLHS | 151 | Q6ZUV0 | |
| IDCSGSHRSLGVHLS | 46 | Q9NP61 | |
| SISESPLEGTSHCHI | 636 | Q8IVF6 | |
| SHSHSPTLCRAVCQL | 606 | P33076 | |
| SSIPVETHRALASCH | 561 | Q9HD20 | |
| CDLVHTRCITPTGTH | 171 | P28799 | |
| THQISLHVASAGPCE | 586 | O00468 | |
| THTGTDPGRTTHRLC | 16 | Q8N1L1 | |
| LCSHAGIQGTSRPSH | 751 | Q9H9G7 | |
| TLAICSSTTASRHHP | 111 | P32970 | |
| PNHHLSGSCTITIEV | 526 | A6H8M9 | |
| TNHGLVPCHISTNLS | 136 | O95199 | |
| CVATHSSHGPQESRA | 301 | Q15109 | |
| HQAPLTARHGLASCT | 206 | Q9NYN1 | |
| AGTLPCGHTETITAH | 461 | P20742 | |
| ASHSRALVGICTGHS | 541 | Q14699 | |
| RPSEERICHAVSTSH | 26 | Q8WYB5 | |
| HGGTVDPTFTSRCTH | 636 | Q6ZW49 | |
| LHCEVLHLPGSSSTQ | 41 | Q92637 | |
| STCGSHTVPSLHAGL | 166 | Q5HY92 | |
| TPTHVTAACAVSRGH | 811 | Q02779 | |
| SSLPCGQDSTITHGH | 3566 | Q8NEZ4 | |
| SSSSHPEHAGRIQSI | 671 | P56524 | |
| ILTTCIPSSGHSRHR | 201 | P19256 | |
| LTTSSPEGCRISHGH | 266 | Q15306 | |
| LSNCETGRLHHTSLP | 186 | Q8WWW8 | |
| TGRLHHTSLPTRCDS | 191 | Q8WWW8 | |
| AGASLCSVPHRTTDV | 191 | Q9BY71 | |
| GNSSHVECPHQTGSL | 346 | Q8NFR9 | |
| PTLNGCHSEISAHSS | 286 | Q8WYN3 | |
| PRLVLSGHTHSACEV | 296 | Q53F39 | |
| CPLCVTSHLHSSRGS | 61 | Q9BZM3 | |
| PLRCSSRGQSITSHH | 141 | A6NKB5 | |
| HPLRHASVLTGCTVA | 141 | Q8NGF3 | |
| TTGSQHCSSRPLELT | 31 | Q8IVL0 | |
| PNTTHSTGSCRSHTA | 256 | P13473 | |
| GVLTQSCTTPHLHSI | 161 | P25963 | |
| TQGTHTTLVTRNCHP | 1731 | P98088 | |
| PISTHIGNELCHSGS | 221 | Q8WVV4 | |
| SLHGPQETLDRTVHC | 106 | Q8IVS2 | |
| TPGHLRSDTEHSTNE | 391 | Q8N573 | |
| VEPCGTNTHASSLQH | 271 | P38398 | |
| SLTHCSSLLEAPQGH | 2711 | O60494 | |
| IQSGTCQHPTSHVSL | 336 | Q9NVR0 | |
| GRASQLSTHLPTCAE | 831 | P26232 | |
| RNHSGTTIPTLECCH | 86 | Q13145 | |
| GVCSIQSSPHREHIL | 241 | Q9BTV6 | |
| THCSRHGSGPNIILT | 606 | Q53ET0 | |
| HTTSPTQRHLCGGSI | 406 | P03951 | |
| CSGSITDHCSLHLPV | 36 | Q96T75 | |
| ATVGENTTLRCHLSP | 41 | Q7KYR7 | |
| LHCEVLHLPGSSSTQ | 41 | P12314 | |
| IDSSRIRSHICSHPG | 361 | Q13118 | |
| PNTRSRGHHNCSESL | 261 | P04233 | |
| QPCSGVLSELVTTHH | 1491 | Q9Y238 | |
| HGPSVCSFEISSLHS | 1891 | Q5THK1 | |
| LHPISTSHSCAETPR | 426 | Q96BN6 | |
| ELRCTAASASPLHTH | 166 | Q9P2B2 | |
| HLSRCQSHPGLTAVS | 206 | Q9H3N8 | |
| CREVHHTDILPSGNT | 566 | Q5VT97 | |
| HIHSSPGRSTCLRQT | 1726 | Q5T011 | |
| LHQHQCRPRSSSTTD | 211 | O75069 | |
| AHDPCVFHSSTVTGL | 441 | O75159 | |
| PIHCISTAGVLLSSH | 606 | Q6T4R5 | |
| CPSSHSSLTERHKIL | 676 | Q15788 | |
| TQCSIHSPSSSSRHL | 106 | O95177 | |
| ASHLPHLTRTLATSC | 201 | O15357 | |
| LPSHSDIHISCLTGL | 1266 | Q8IZU2 | |
| SSPSTHHIGVCSLAR | 1236 | Q7Z745 | |
| SPLGLEIHTTSNCQH | 206 | Q969H4 | |
| HPGEITNAHNSSCIS | 66 | Q8IWZ8 | |
| HQRIHTGESSTCPSL | 831 | Q8NHY6 | |
| QTSSLTCHRRLHTGE | 281 | Q86XN6 | |
| HCSGQREAISSHPLQ | 31 | Q6ZSR3 | |
| CTSSGLTEHVRTHTG | 431 | Q96MU6 | |
| CSPTLRIHERTHTGE | 291 | P52737 | |
| RCASTTHELHSPENL | 911 | Q8N2C7 | |
| QEHHGAAPTCTSLST | 881 | Q76I76 | |
| CDATHVSGPTQHLSR | 1271 | Q9BX26 | |
| ELLGRASPHCHCSTT | 396 | Q8WWF5 | |
| GHPVSTLSRSSCDLQ | 1036 | Q8IZH2 | |
| LSPTTGHCNSGRTRH | 2801 | P21359 | |
| HQSSISHPLASCAGL | 1246 | Q68DE3 | |
| QHVTLRCSPISGHTS | 36 | A0A0A0MS05 | |
| TRPSNHGKELCVLSH | 316 | Q8IYW5 | |
| TPGDHQICLHSNSTR | 106 | Q7Z7H5 | |
| PDSSSCLIHERTHTG | 291 | Q9Y2A4 | |
| CPSSLQSHERTHTGE | 376 | Q9Y2A4 | |
| LENPCSESHSLSHTR | 546 | Q6PF04 | |
| GTHTVNSDRLHTPSS | 321 | Q9C0K7 | |
| SLLTQETCGHRTPTS | 71 | P35711 | |
| DITRHVNSCHQGTPA | 1271 | P52746 | |
| LHSISSHPSGIVSLC | 401 | Q8N5T2 | |
| SCEITHPSHTSGQIN | 261 | Q6N021 | |
| DSQPCTHGHLRVTLV | 936 | Q9HD43 | |
| TEGRSVNHLCPTSSD | 221 | O95405 |